您的购物车当前为空
Anticanceragent 135(compound 26h)为一有效的雄激素受体(AR)拮抗剂,能够阻断AR核转位并抑制AR/AR-V7异二聚化,以抑制下游基因转录。该化合物在前列腺癌异种移植模型中展现出显著疗效。
Anticanceragent 135(compound 26h)为一有效的雄激素受体(AR)拮抗剂,能够阻断AR核转位并抑制AR/AR-V7异二聚化,以抑制下游基因转录。该化合物在前列腺癌异种移植模型中展现出显著疗效。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
Anticancer agent 135 相关产品
| 产品描述 | Anticancer agent 135 (compound 26h) acts as a potent androgen receptor (AR) antagonist, effectively blocking AR nuclear translocation and inhibiting AR/AR-V7 heterodimerization to suppress downstream gene transcription. This compound demonstrates strong efficacy in prostate cancer xenograft models [1]. |
| 分子量 | 458.5 |
| 分子式 | C23H21F3N4OS |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容